MedTrace Logo

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

NCT00288106 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 961

Last updated 2015-09-30

No results posted yet for this study

Summary

RATIONALE: Learning about the long-term effects of chemoprevention drugs, such as finasteride, in patients with prostate cancer may help doctors plan better treatment and follow-up care.

PURPOSE: This clinical trial is following patients who were diagnosed with prostate cancer while undergoing treatment with either finasteride or a placebo on the Prostate Cancer Prevention Trial (PCPT).

Conditions

Interventions

OTHER

Follow-up

No additional drug was given; clinical observation of men diagnosed with prostate cancer who were previously randomized and treated on PCPT

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Ian M. Thompson, MD · The University of Texas Health Science Center at San Antonio

  • Scott M. Lippman, MD, FACP · M.D. Anderson Cancer Center

  • E. David Crawford, MD · University of Colorado, Denver

Eligibility

Min Age
55 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288106 on ClinicalTrials.gov